Central Serous Chorioretinopathy Following Oral Use of Adulterated Honey Mixed with Tadalafil: A Case Report

Background Central serous chorioretinopathy (CSCR) is an idiopathic condition characterized by serous retinal detachment and/or retinal pigment epithelial (RPE) detachment, the condition associated with a fluid leak through the RPE into subretinal space. This article reports on an unusual case of CSCR following taking adulterated honey mixed with tadalafil powder. Case Presentation A 38-year-old male, not known to have any medical illnesses, came to our ophthalmology clinic complaining of sudden onset of blurred central vision in the left eye for five days after taking an adulterated honey which was claimed to improve sexual performance. On taking a history, the patient denied taking any medications or past eye trauma or surgery. On detailed ophthalmologic examination, the best-corrected visual acuity (BCVA) was 20/20 in the right eye and 20/80 in the left eye. Dilated fundus examination of the right eye showed a flat retina, normal macular reflex, healthy optic nerve head and the left eye showed blunt foveal reflex with neurosensory retinal detachment at the macula and subretinal fluid. Optical coherence tomography (OCT) of the left eye showed marked macular thickening, leading to the impression of central serous chorioretinopathy (CSCR). Four weeks after stopping the adulterated honey, BCVA improved to 20/20 in the left eye, with complete resolution of subretinal fluids. Conclusion Our case adds to recently reported cases of a link between tadalafil and CSCR.

[1]  J. Carballido,et al.  Sildenafil/Viagra in the treatment of premature ejaculation , 2019, International Journal of Impotence Research.

[2]  M. Moschos,et al.  Pathophysiology of visual disorders induced by phosphodiesterase inhibitors in the treatment of erectile dysfunction , 2016, Drug design, development and therapy.

[3]  Jason Noble,et al.  Central serous chorioretinopathy: update on pathophysiology and treatment. , 2013, Survey of ophthalmology.

[4]  L. Yannuzzi TYPE-A BEHAVIOR AND CENTRAL SEROUS CHORIORETINOPATHY , 2012, Retina.

[5]  K. Freund,et al.  THE EFFECTS OF SILDENAFIL CITRATE ON CHOROIDAL THICKNESS AS DETERMINED BY ENHANCED DEPTH IMAGING OPTICAL COHERENCE TOMOGRAPHY , 2011, Retina.

[6]  Frederick W. Fraunfelder,et al.  Central Serous Chorioretinopathy Associated With Sildenafil , 2008, Retina.

[7]  J. Pulido,et al.  Forgotten exogenous corticosteroid as a cause of central serous chorioretinopathy , 2008, Clinical ophthalmology.

[8]  D. Gagnon,et al.  Risk factors for central serous chorioretinopathy: a case-control study. , 2004, Ophthalmology.

[9]  G. Lang,et al.  [Central serous chorioretinopathy. Clinical, fluorescein angiography and demographic aspects]. , 1998, Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft.

[10]  M. Doly,et al.  Effect of a cGMP-specific phosphodiesterase inhibitor on retinal function. , 1998, European journal of pharmacology.

[11]  D. Talwar,et al.  Endogenous cortisol profile in patients with central serous chorioretinopathy , 1997, The British journal of ophthalmology.

[12]  J. Donald,et al.  Pathogenesis of Disciform Detachment of the Neuroepithelium: II. Idiopathic Central Serous Choroidopathy , 1967 .

[13]  J. Doggart Central serous retinopathy. , 1949, The Medical journal of Australia.

[14]  S. Gifford,et al.  CENTRAL ANGIOSPASTIC RETINOPATHY , 1939 .

[15]  L. L. Sloan,et al.  Idiopathic Flat Detachment of the Macula , 1936 .